MicroRNA Dynamics in Depression Pathophysiology

MicroRNAs are pivotal regulators of gene expression in the brain, orchestrating the fine-tuning of neural circuits that underlie mood and cognition. In major depressive disorder, dynamic alterations in microRNA levels have been linked to synaptic remodelling, neuroinflammatory responses and stress hormone signalling. Dysregulated microRNA expression can amplify vulnerability to environmental stressors by targeting cohorts of mRNAs involved in neurotransmitter release, dendritic spine morphology and neurotrophic support. Conversely, adaptive changes in specific microRNAs can confer resilience by repressing pro-apoptotic or pro-inflammatory pathways. This dual role positions microRNAs as both mediators of pathophysiology and promising biomarkers for diagnosis or treatment response. Across preclinical models and clinical cohorts, convergence on pathways such as MAPK/Wnt and JAK2/STAT3 highlights the global significance of microRNA-dependent networks. Therapeutic strategies that restore balanced microRNA activity—whether by mimics, inhibitors or modulation of upstream epigenetic mechanisms—offer new avenues for personalised intervention in depression.

Research from Nature Portfolio

Recent studies in stress paradigms have identified miR-483-5p as a rapid responder in the basolateral amygdala. Following acute stress, miR-483-5p is enriched at synapses and directly represses multiple stress-associated genes, leading to selective remodelling of dendritic arbour and conversion of immature filopodia into mature spines. Experimental upregulation of miR-483-5p reduces anxiety-like behaviour, whereas blocking its activity exacerbates stress responses, pinpointing a precise molecular switch for resilience. In parallel, clinical and translational work has spotlighted a quartet of microRNAs—miR-146a-5p, miR-146b-5p, miR-425-3p and miR-24-3p—as consistent markers of antidepressant efficacy. These microRNAs modulate components of the MAPK and Wnt signalling cascades, and their expression tracks treatment response across human trials and animal models. Together, these findings establish both mechanistic insight and biomarker potential for microRNA dynamics in depression.

MicroRNA Dynamics in Depression Pathophysiology publication trend

The graph below shows the total number of articles in microrna dynamics in depression pathophysiology across all publications each year (not limited to Nature Index journals).

Technical terms

microRNA: Non-coding RNAs of 20–24 nucleotides that regulate gene expression post-transcriptionally by binding target mRNAs.

Synaptic plasticity: The capacity of synapses to strengthen or weaken over time in response to increases or decreases in activity.

Circular RNA (circRNA): Covalently closed RNA molecules that can act as sponges for microRNAs, modulating their availability.

Microglial activation: A reactive state of the brain’s resident immune cells characterised by cytokine release and modulation of neuronal function.

References

1. Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential. Signal Transduction and Targeted Therapy (2023).
2. miR-483-5p offsets functional and behavioural effects of stress in male mice through synapse-targeted repression of Pgap2 in the basolateral amygdala. Nature Communications (2023).
3. MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes. Nature Communications (2017).
4. CircDYM ameliorates depressive-like behavior by targeting miR-9 to regulate microglial activation via HSP90 ubiquitination. Molecular Psychiatry (2018).
5. Chronic corticosterone-mediated dysregulation of microRNA network in prefrontal cortex of rats: relevance to depression pathophysiology. Translational Psychiatry (2015).